Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 1:16 AM
Study NCT ID:
NCT07399704
Status:
RECRUITING
Last Update Posted:
2026-03-19
First Post:
2025-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease
Sponsor:
Azafaros A.G.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2030-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-08-07
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-17
First Submit QC Date:
None
Study First Post Date:
2026-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-18
Last Update Post Date:
2026-03-19
Last Update Post Date Type:
ACTUAL